WESFARMERS LIMITED (WES)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

WES

WES - WESFARMERS LIMITED

FNArena Sector : Consumer Products & Services
Year End: June
GICS Industry Group : Food & Staples Retailing
Debt/EBITDA: 1.97
Index: ASX20 | ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Wesfarmer is an Australian conglomerate with interests predominantly in Australian and New Zealand retail companies. It owns Bunnings, Kmart, Officeworks and Target, amongst others. Founded as the Westralian Farmers Co-operative in 1914 it became a listed entity in November 1984.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$89.52

07 Aug
2025

0.640

OPEN

$89.00

0.72%

HIGH

$89.74

1,186,898

LOW

$88.74

TARGET
$73.233 -18.2% downside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ALD . MPA . PFP .
FNARENA'S MARKET CONSENSUS FORECASTS
WES: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 225.7 233.6 xxx
DPS (cps) xxx 198.0 202.7 xxx
EPS Growth xxx 3.6% 3.5% xxx
DPS Growth xxx 3.7% 2.4% xxx
PE Ratio xxx N/A 38.6 xxx
Dividend Yield xxx N/A 2.2% xxx
Div Pay Ratio(%) xxx 87.7% 86.8% xxx

Dividend yield today if purchased 3 years ago: 4.24%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 2.20

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 03/09 - ex-div 107c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx225.7
DPS All xxxxxxxxxxxxxxx198.0
Sales/Revenue xxxxxxxxxxxxxxx44,047.0 M
Book Value Per Share xxxxxxxxxxxxxxx756.5
Net Operating Cash Flow xxxxxxxxxxxxxxx4,594.0 M
Net Profit Margin xxxxxxxxxxxxxxx5.81 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx30.32 %
Return on Invested Capital xxxxxxxxxxxxxxx13.82 %
Return on Assets xxxxxxxxxxxxxxx9.02 %
Return on Equity xxxxxxxxxxxxxxx30.32 %
Return on Total Capital xxxxxxxxxxxxxxx20.04 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx1,318.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx1,165 M
Long Term Debt xxxxxxxxxxxxxxx10,113 M
Total Debt xxxxxxxxxxxxxxx11,278 M
Goodwill - Gross xxxxxxxxxxxxxxx4,082 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx835 M
Price To Book Value xxxxxxxxxxxxxxx8.62

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx1,076.0 M
Capex % of Sales xxxxxxxxxxxxxxx2.44 %
Cost of Goods Sold xxxxxxxxxxxxxxx37,267 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx2,841 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx960 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

-0.5

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

5

xxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

21/07/2025

4

Lighten

$72.00

-19.57%

In light of retail industry data and discussions, as well as changes to lithium price forecasts, Ord Minnett has reviewed earnings forecasts for Wesfarmers.

The broker notes the expected loss at Covalent Lithium at -$60m meets the company's guidance, with the projected loss for FY26 up by 14%.

Retail data supports a rise in Kmart's earnings forecasts for 2H2025, while competition continues to impact margins for Healthcare. Bunnings' forecasts remain unchanged, and better performances for Chemicals, Energy, and Fertiliser are now expected.

A Lighten rating is retained. The target price lifts to $72 from $69, with the analyst raising EPS estimates by 2% for FY25 and 0.2% for FY26.

Morgans

xx/xx/xxxx

4

xxxxxxxxx xx xxxx xxxx xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

27/05/2025

4

Underweight

$73.10

-18.34%

Jarden views the latest Strategy Day as the most upbeat for Wesfarmers, with management discussing higher return on investment and several growth initiatives, including slight earnings upgrades to the broker's outlook for Health, Officeworks, and Kmart.

Despite the more positive view on those divisions, the slight downward earnings estimate revisions relate to Mount Holland, where lithium losses are higher at -$60m due to persistent weak market pricing.

Jarden believes financial services are the missing link in the group's portfolio.

Target price rises to $73.10 from $67.50. No change to Underweight rating. The broker trims EPS estimates by -1% to -4% for FY25–FY27.

FORECAST
Jarden forecasts a full year FY25 dividend of 204.00 cents and EPS of 231.50 cents.
Jarden forecasts a full year FY26 dividend of 228.00 cents and EPS of 257.30 cents.
Access Extra Coverage Research History >

WES STOCK CHART

FNArena News on WES

1
Rudi’s View: AI Updates, Hot Favourites & First August Results

Aug 07 2025 - Rudi's View
2
Rudi’s View: Bega Cheese, Cettire, Harvey Norman, Sigma, SiteMinder & More

Jul 24 2025 - Rudi's View
3
Rudi’s View: Extreme Bifurcation Ahead Of August

Jul 23 2025 - Rudi's View
4
Rudi’s View: Aussie Broadband, oOh!media, Paladin Energy, Seek, Xero & More

Jul 17 2025 - Rudi's View
5
Rudi’s View: Gold stocks & Miners, DigiCo, Pinnacle & More

Jul 10 2025 - Rudi's View

Latest Consumer Products & Services News

1
Undervalued Flight Centre Awaits Travel Recovery

Aug 05 2025 - Australia
2
Aristocrat Leisure Eyeing Up All-Time Highs

Aug 05 2025 - Technicals
3
Consumer Spending Not What It Used To Be

Aug 04 2025 - Australia
4
Telstra Shares Enjoying Firm Up-Trend

Jul 17 2025 - Technicals
5
In Brief: Austal, Superloop, Motorcycle Holdings & Nanosonics

Jul 04 2025 - Weekly Reports
6
Reece Battling Tariffs, Competition & Cost Crises

Jul 01 2025 - Australia
7
Treasury’s Transition Turbulence

Jun 26 2025 - Australia
8
Collins Foods’ Finger-Lickin’ Turnaround

Jun 25 2025 - Small Caps
9
New Broom Clearing The Decks For Adairs

Jun 25 2025 - Small Caps
10
Metcash Outlook: Tobacco Sales vs Rate Cuts

Jun 24 2025 - Australia